PS-341 (bortezomib)

DRUG2 trials

Sponsors

M.D. Anderson Cancer Center, Baylor College of Medicine

Conditions

Fallopian Tube CancerOvarian CancerPrimary Peritoneal CancerProstate Neoplasms

Phase 1

PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer

CompletedNCT00059618

M.D. Anderson Cancer CenterFallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer

Start: 2003-04-30End: 2007-04-30Updated: 2012-08-02

Phase 2

PS-341 Followed by Removal of Prostate for Those With Prostate Cancer

CompletedNCT00425503

Baylor College of MedicineProstate Neoplasms

Start: 2001-12-31End: 2013-12-31Updated: 2014-04-21